A research team at NYU Langone Health and Sage Bionetworks has been awarded a $25 million grant to establish the data hub and coordinating center for the National Institutes of Health's ...
With the appointment of Dr. Brem, Galectin continues to strengthen its Board with leaders who bring deep scientific and clinical expertise to support the Company’s strategic priorities and upcoming ...
In ACS Central Science, researchers report the discovery of a snail-derived compound that blocks clot formation while still ...
S-606001 has the potential to become the first oral substrate reduction therapy for Pompe diseaseOSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer ...
ReNeuron Group Limited, a leading UK biotechnology company, has joined Swansea University’s Institute of Life Science (ILS) in a new strategic research partnership to advance next-generation exosome ...
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension ...
New data hub will accelerate development and adoption of human-based New Approach Methodologies The NYU Langone-Sage ...
Too frequently, clinicians think all they need to say is, ‘I know better,’ and that’s not what patients need to hear,” said Christy J.W. Ledford, PhD, communication scientist at the Medical College of ...
Scientists in Shanghai have developed a potentially groundbreaking treatment for diabetes that targets the root cause of the disease rather than just its symptoms, offering hope for a functional cure.
Good day, and thank you for standing by. Welcome to the Alvotech Q4 2025 and Full Year 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being ...
The team, in collaboration with Shanghai Changzheng Hospital, has conducted regenerative islet transplantation surgeries using autologous and allogeneic stem cell-derived islets on three patients with ...
The Citizens Life Sciences Conference 2026 March 11, 2026 1:40 PM EDTCompany ParticipantsSteven Harr - President, CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results